After more than 16 years in clinical research, Asma reflects on the operational lesson behind this conversation—and why it matters for the people responsible for participants, sites, data, and trial continuity.
The CRA sits between sponsor and site
Expectations, clarifications, enrollment concerns, safety issues, deviations, queries, and escalation decisions all move through the CRA. The quality of that communication can determine whether risks are surfaced early.
Inspection without partnership has limits
A CRA may document findings correctly and still create defensiveness. When sites stop communicating openly, issues remain hidden longer and operational risk grows.
What exceptional communication looks like
Effective CRAs address problems without humiliating staff, preserve sponsor expectations without creating unnecessary conflict, and help sites understand what must change and why.
A better question for every visit
Instead of asking only what must be documented, ask what the site needs today to run the study more compliantly and with less risk. Meaningful monitoring should leave a site clearer, more aware, and operationally stronger.
Experience becomes valuable when it helps the next professional recognize risk earlier, communicate more clearly, and carry responsibility more thoughtfully.
Continue the conversation
What has your own experience taught you about this topic? Share a question or perspective with the Syncreon Research Lounge community.
Share your perspective